Hayton R
Can Fam Physician. 2010; 21(11):71-3.
PMID: 20469258
PMC: 2274761.
Shanks R
Ulster Med J. 1994; 63(1):52-75.
PMID: 8658996
PMC: 2449090.
Kupper W, Hamm C, BLEIFELD W
Br J Clin Pharmacol. 1982; 13(Suppl 2):309S-312S.
PMID: 7104152
PMC: 1402158.
DOI: 10.1111/j.1365-2125.1982.tb01932.x.
Shanks R, Brick I, Hutchison K, Roddie I
Br Med J. 1967; 1(5540):610-2.
PMID: 6067167
PMC: 1841453.
DOI: 10.1136/bmj.1.5540.610.
VOGEL J, BLOUNT Jr S
Br Heart J. 1967; 29(3):310-6.
PMID: 6023724
PMC: 459151.
DOI: 10.1136/hrt.29.3.310.
Haemodynamic effects of beta-adrenergic blockade.
AStrom H
Br Heart J. 1968; 30(1):44-9.
PMID: 5637556
PMC: 459206.
DOI: 10.1136/hrt.30.1.44.
Clinical, electrocardiographic, and haemodynamic effects of long-term use of propranolol in Prinzmetal's variant angina pectoris.
Guazzi M, Magrini F, Fiorentini C, Polese A
Br Heart J. 1971; 33(6):889-94.
PMID: 5120235
PMC: 458444.
DOI: 10.1136/hrt.33.6.889.
Measurement of regional myocardial perfusion in man with 133 xenon and a scintillation camera.
Cannon P, Dell R, DWYER Jr E
J Clin Invest. 1972; 51(4):964-77.
PMID: 5014620
PMC: 302210.
DOI: 10.1172/JCI106891.
Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise.
Prichard B, GILLAM P
Br Heart J. 1971; 33(4):473-80.
PMID: 4997528
PMC: 487199.
DOI: 10.1136/hrt.33.4.473.
New trends in the treatment of angina pectoris.
Mason D, SPANN Jr J, Zelis R
Calif Med. 1969; 111(3):159-64.
PMID: 4980881
PMC: 1503625.
Clinical evaluation of verapamil in angina pectoris.
Sandler G, Clayton G, Thornicroft S
Br Med J. 1968; 3(5612):224-7.
PMID: 4969551
PMC: 1986217.
DOI: 10.1136/bmj.3.5612.224.
Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy.
Hubner P, Ziady G, Lane G, Hardarson T, SCALES B, Oakley C
Br Heart J. 1973; 35(11):1116-23.
PMID: 4586631
PMC: 458765.
DOI: 10.1136/hrt.35.11.1116.
Clinical evaluation of oxprenolol in angina pectoris.
Sandler G, Pistevos A
Br Heart J. 1972; 34(8):847-50.
PMID: 4560824
PMC: 486991.
DOI: 10.1136/hrt.34.8.847.
Comparison of effects of propranolol and practolol on exercise tolerance in angina pectoris.
Coltart D
Br Heart J. 1971; 33(1):62-4.
PMID: 4395792
PMC: 487141.
DOI: 10.1136/hrt.33.1.62.
A comparison of the effects of propranolol and practolol on the exercise tolerance in angina pectoris.
Coltart D, Hamer J
Br J Pharmacol. 1970; 40(1):147P-148P.
PMID: 4395080
PMC: 1702711.
Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
Coltart D, SHAND D
Br Med J. 1970; 3(5725):731-4.
PMID: 4394650
PMC: 1701661.
DOI: 10.1136/bmj.3.5725.731.
Practolol in treatment of angina pectoris. A double-blind trial.
George C, NAGLE R, PENTECOST B
Br Med J. 1970; 2(5706):402-4.
PMID: 4392984
PMC: 1700308.
DOI: 10.1136/bmj.2.5706.402.
Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
Sandler G, Clayton G
Br Med J. 1970; 2(5706):399-402.
PMID: 4392983
PMC: 1700305.
DOI: 10.1136/bmj.2.5706.399.
Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.
Wilson A, Brooke O, Lloyd H, Robinson B
Br Med J. 1969; 4(5680):399-401.
PMID: 4390958
PMC: 1629770.
DOI: 10.1136/bmj.4.5680.399.
[Adrenergic alpha and beta receptors and their specific inhibitors].
Muscholl E, Rahn K
Klin Wochenschr. 1968; 46(3):113-9.
PMID: 4385910
DOI: 10.1007/BF01727368.
